Breaking News Instant updates and real-time market news.

NTWK

NetSol Technologies

$2.68 /

-0.13 (-4.63%)

08:15
09/28/20
09/28
08:15
09/28/20
08:15

NetSol Technologies reports Q4 10c vs. 30c last year

Reports Q4 revenues $13.6M vs. $17.3M in prior year period. "While we are still working through a challenging market environment, during the fiscal fourth quarter we recorded meaningful sales milestones, drove incrementally improved results and were able to generate another year of profitability," said NETSOL Co-Founder, Chairman and CEO Najeeb Ghauri. "We entered fiscal 2020 coming off a record top and bottom line performance and in the strongest position in our history. At that same time, we introduced a multi-pronged growth strategy designed, during regular economic conditions, to diversify and expand our total and recurring revenue streams, ultimately propelling NETSOL to its next phase of commercial prosperity. Over the past few months, we, like most businesses, were forced to adapt to a radically different working environment than we had planned. Despite these unfavorable conditions, we have continued to forge a path ahead and, in the meantime, have taken decisive actions to reduce costs, which will support our long-term sustainability. Looking ahead to fiscal 2021, we have many reasons for cautious optimism. We've made encouraging progress in expanding our sales footprint in North America and Europe, driving year-over-year growth, respectively, and have also made key leadership additions to head up both regions. Last month, we went live with the first North American customer for our subscription, cloud-based NFS Ascent offering, which we expect to leverage toward additional agreements in the future. With several COVID-19 driven purchasing delays beginning to move ahead, we also have a significant pipeline of opportunities in the coming year. As our global operations conservatively pick back up, we will look to regain the prior year's momentum and resume our plans for a diversified, progressive growth strategy. NETSOL remains a digital-first and SaaS-focused organization, and we will continue to lead with our technology to deliver innovative ways to help our customers improve their operations today and prepare for the many, disruptive challenges of the new mobility economy. While we continue to see strong traction and engagement globally for Ascent, our SaaS offering has been particularly well received in Europe and North America. Our platform is being validated with initial sales in both regions and a number of deals that are currently in our pipeline. The overall sales environment remains challenging due to the travel restrictions in place and uncertainty around the global economy, which has, in some cases, delayed our ability to close deals over the last quarters, but we are continuing to move forward."

  • 28

    Sep

TODAY'S FREE FLY STORIES

Hot Stocks
IGC completes final cohort of Phase 1 trial on Alzheimer's patients » 18:54
06/23/21
06/23
18:54
06/23/21
18:54
IGC

India Globalization Capital

$1.46 /

-0.01 (-0.68%)

India Globalization…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

Hot Stocks
Box CEO: We're executing a very effective strategy » 18:48
06/23/21
06/23
18:48
06/23/21
18:48
BOX

Box

$25.22 /

+0.02 (+0.08%)

In an interview on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

04/09/21 DA Davidson
Box price target lowered to $22 from $25 at DA Davidson
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
03/23/21 KeyBanc
Box price target raised to $27 from $22 at KeyBanc
BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

Hot Stocks
J.M. Smucker CEO sells 10K shares of common stock » 18:44
06/23/21
06/23
18:44
06/23/21
18:44
SJM

J.M. Smucker

$129.06 /

-1.42 (-1.09%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

06/04/21 Stifel
J.M. Smucker price target raised to $135 from $125 at Stifel
06/04/21 Deutsche Bank
J.M. Smucker price target raised to $140 from $138 at Deutsche Bank
06/04/21 BofA
J.M. Smucker price target raised to $140 from $124 at BofA
05/20/21 Deutsche Bank
J.M. Smucker named 'Catalyst Call: Buy Idea' at Deutsche Bank
SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

Upgrade
Magna upgraded to Buy from Neutral at Goldman Sachs » 18:42
06/23/21
06/23
18:42
06/23/21
18:42
MGA

Magna

$92.86 /

+0.24 (+0.26%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

06/21/21 Edward Jones
Magna upgraded to Buy from Hold at Edward Jones
05/31/21 BMO Capital
Magna price target raised to $115 from $108 at BMO Capital
05/10/21 Credit Suisse
Magna price target raised to $120 from $115 at Credit Suisse
04/20/21 Morgan Stanley
Fisker remains 'top ranked' EV related SPAC startup, says Morgan Stanley
MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

Recommendations
Patterson Companies price target lowered to $41 from $44 at Piper Sandler » 18:39
06/23/21
06/23
18:39
06/23/21
18:39
PDCO

Patterson Companies

$30.95 /

-4.18 (-11.90%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

08:42 Today Piper Sandler
Patterson earnings pullback a buying opportunity, says Piper Sandler
06/17/21
Fly Intel: Top five analyst upgrades
06/17/21 Piper Sandler
Patterson Companies upgraded to Overweight from Neutral at Piper Sandler
03/03/21 Piper Sandler
Piper stays Neutral Patterson despite execution due to 'lingering uncertainty'
PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

Periodicals
BuzzFeed close to go-public deal with 890 5th Avenue Partners, WSJ reports » 18:11
06/23/21
06/23
18:11
06/23/21
18:11
ENFA

890 5th Avenue Partners

$9.79 /

-0.01 (-0.10%)

BuzzFeed is nearing a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENFA 890 5th Avenue Partners
$9.79 /

-0.01 (-0.10%)

ENFA 890 5th Avenue Partners
$9.79 /

-0.01 (-0.10%)

Syndicate
Doximity 23.3M share IPO priced at $26.00 » 18:05
06/23/21
06/23
18:05
06/23/21
18:05
DOCS

Doximity

/

+

The deal priced above the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Jun
Syndicate
Confluent 23M share IPO priced at $36.00 » 18:04
06/23/21
06/23
18:04
06/23/21
18:04
CFLT

Confluent

/

+

The deal priced above the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 24
    Jun
Syndicate
Portage Biotech files to sell common stock, no amount given » 17:50
06/23/21
06/23
17:50
06/23/21
17:50
PRTG

Portage Biotech

$35.28 /

+2.38 (+7.23%)

Cantor Fitzgerald and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Jun
Initiation
PayPal initiated with a Buy at DA Davidson » 17:49
06/23/21
06/23
17:49
06/23/21
17:49
PYPL

PayPal

$288.11 /

+1.22 (+0.43%)

DA Davidson initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

12:16 Today Credit Suisse
PayPal pricing update raises confidence in five-year outlook, says Credit Suisse
06/21/21 BofA
PayPal's announced price increase already in guidance, says BofA
06/21/21 Barclays
PayPal price increase to bring 2022 earnings upside, says Barclays
05/07/21 BMO Capital
PayPal price target raised to $256 from $241 at BMO Capital
PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

Initiation
Square initiated with a Buy at DA Davidson » 17:38
06/23/21
06/23
17:38
06/23/21
17:38
SQ

Square

$238.66 /

+2.68 (+1.14%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

05/25/21 Baird
Square comps starting to get more difficult, says Baird
05/20/21 Tigress Financial
Square shares have close to 50% upside potential, says Tigress Financial
05/10/21 BMO Capital
Square price target raised to $269 from $237 at BMO Capital
05/07/21 JPMorgan
Square price target raised to $300 from $250 at JPMorgan
SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

Conference/Events
G-III Apparel participates in a conference call with UBS » 17:38
06/23/21
06/23
17:38
06/23/21
17:38
GIII

G-III Apparel

$32.57 /

+0.53 (+1.65%)

Consumer Goods Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

06/08/21 B. Riley
G-III Apparel price target raised to $41 from $39 at B. Riley
06/08/21 Barclays
G-III Apparel price target raised to $30 from $27 at Barclays
03/19/21 B. Riley Securities
G-III Apparel price target raised to $38 from $33 at B. Riley Securities
03/19/21 Barclays
G-III Apparel price target raised to $27 from $24 at Barclays
GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

Conference/Events
UBS quantitative analyst to hold analyst/industry conference call » 17:35
06/23/21
06/23
17:35
06/23/21
17:35

Analysts provide Quant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Artius Acquisition shareholders approve Origin Materials business combination » 17:35
06/23/21
06/23
17:35
06/23/21
17:35
ORGN

Origin Materials

/

+

, AACQ

Artius Acquisition

$9.67 /

+0.325 (+3.48%)

Artius Acquisition (AACQ)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORGN Origin Materials
/

+

AACQ Artius Acquisition
$9.67 /

+0.325 (+3.48%)

ORGN Origin Materials
/

+

AACQ Artius Acquisition
$9.67 /

+0.325 (+3.48%)

05/03/21 Craig-Hallum
Artius Acquisition initiated with a Buy at Craig-Hallum
AACQ Artius Acquisition
$9.67 /

+0.325 (+3.48%)

Hot Stocks
Casey's General Stores director Bridgewater sells almost $599K in company shares » 17:34
06/23/21
06/23
17:34
06/23/21
17:34
CASY

Casey's General Stores

$198.27 /

-0.51 (-0.26%)

Casey's General…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

06/22/21
Fly Intel: Top five analyst downgrades
06/22/21 Goldman Sachs
Casey's General Stores downgraded to Neutral from Buy at Goldman Sachs
06/22/21 Goldman Sachs
Alimentation Couche-Tard upgraded to Buy from Neutral at Goldman Sachs
06/10/21 Stephens
Casey's General Stores price target lowered to $230 from $250 at Stephens
CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

Conference/Events
FDA Oncologic Drugs Advisory Committee to hold Virtual Meeting » 17:32
06/23/21
06/23
17:32
06/23/21
17:32
INCY

Incyte

$85.11 /

+0.06 (+0.07%)

The Committee discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

07:10 Today Benchmark
Incyte's retifanlimab does not seem likely to be approved, says Benchmark
02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

Hot Stocks
Granite wins $20M bike trail project in California » 17:31
06/23/21
06/23
17:31
06/23/21
17:31
GVA

Granite

$39.80 /

+0.295 (+0.75%)

Granite has been awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GVA Granite
$39.80 /

+0.295 (+0.75%)

GVA Granite
$39.80 /

+0.295 (+0.75%)

04/15/21 DA Davidson
Granite upgraded to Buy from Neutral at DA Davidson
04/15/21 DA Davidson
Granite upgraded to Buy from Neutral at DA Davidson
03/31/21 DA Davidson
Granite price target raised to $35 from $17 at DA Davidson
06/25/20 DA Davidson
Granite Construction price target lowered to $17 from $30 at DA Davidson
GVA Granite
$39.80 /

+0.295 (+0.75%)

GVA Granite
$39.80 /

+0.295 (+0.75%)

Hot Stocks
KB Home raises FY21 housing revenue view to $5.9B-$6.1B from $5.7B-$6.1B » 17:27
06/23/21
06/23
17:27
06/23/21
17:27
KBH

KB Home

$43.35 /

+0.1 (+0.23%)

Raises FY21 average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

Hot Stocks
KB Home sees Q3 community count up 5%  17:27
06/23/21
06/23
17:27
06/23/21
17:27
KBH

KB Home

$43.35 /

+0.1 (+0.23%)

 
ShowHide Related Items >><<
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

Hot Stocks
KB Home sees Q3 housing revenue $1.5B-$1.58B » 17:24
06/23/21
06/23
17:24
06/23/21
17:24
KBH

KB Home

$43.35 /

+0.1 (+0.23%)

Sees Q3 average selling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

Syndicate
NeuBase Therapeutics files to sell 308.6K shares of common stock for holders  17:22
06/23/21
06/23
17:22
06/23/21
17:22
NBSE

NeuBase Therapeutics

$5.05 /

+0.13 (+2.64%)

 
ShowHide Related Items >><<
NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

06/01/21 H.C. Wainwright
NeuBase Therapeutics price target lowered to $15 from $18 at H.C. Wainwright
05/18/21 Chardan
NeuBase Therapeutics named a top pick for 2021 at Chardan
02/12/21 H.C. Wainwright
NeuBase Therapeutics price target raised to $18 from $15 at H.C. Wainwright
NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

  • 22
    Apr
NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

Downgrade
Pirelli downgraded to Sell from Neutral at Goldman Sachs » 17:15
06/23/21
06/23
17:15
06/23/21
17:15
PLLIF

Pirelli

$5.50 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLLIF Pirelli
$5.50 /

+ (+0.00%)

05/14/21 Morgan Stanley
Pirelli price target raised to EUR 4.90 from EUR 4.80 at Morgan Stanley
05/05/21 JPMorgan
Pirelli price target raised to EUR 4.40 from EUR 4 at JPMorgan
04/28/21 UBS
Pirelli price target raised to EUR 5 from EUR 4.50 at UBS
04/01/21 Stifel
Pirelli downgraded to Hold from Buy at Stifel
Initiation
Opco starts Oaktree Specialty Lending with an Outperform on 'strong' credit » 17:08
06/23/21
06/23
17:08
06/23/21
17:08
OCSL

Oaktree Specialty Lending

$6.74 /

+0.025 (+0.37%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCSL Oaktree Specialty Lending
$6.74 /

+0.025 (+0.37%)

OCSL Oaktree Specialty Lending
$6.74 /

+0.025 (+0.37%)

16:23 Today Oppenheimer
Oaktree Specialty Lending initiated with an Outperform at Oppenheimer
03/05/21 Hovde Group
Oaktree Specialty Lending initiated with an Outperform at Hovde Group
OCSL Oaktree Specialty Lending
$6.74 /

+0.025 (+0.37%)

Conference/Events
Fulcrum Therapeutics to host conference call » 17:05
06/23/21
06/23
17:05
06/23/21
17:05
FULC

Fulcrum Therapeutics

$9.13 /

+0.25 (+2.82%)

Management discusses the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

04/26/21 Credit Suisse
Fulcrum Therapeutics assumed with an Outperform at Credit Suisse
03/22/21 Credit Suisse
Fulcrum Therapeutics initiated with an Outperform at Credit Suisse
03/04/21 Piper Sandler
Fulcrum Therapeutics price target lowered to $20 from $22 at Piper Sandler
03/01/21 Stifel
Fulcrum Therapeutics initiated with a Buy at Stifel
FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

  • 20
    Jan
Hot Stocks
Celanese acquires POM technology, sales agreements from Grupa Azoty » 17:00
06/23/21
06/23
17:00
06/23/21
17:00
CE

Celanese

$148.72 /

+0.105 (+0.07%)

Celanese Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CE Celanese
$148.72 /

+0.105 (+0.07%)

CE Celanese
$148.72 /

+0.105 (+0.07%)

06/21/21 Baird
Celanese remains a top pick at Baird
06/09/21 Wolfe Research
Celanese initiated with an Outperform at Wolfe Research
06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 Goldman Sachs
Celanese downgraded to Neutral from Buy at Goldman Sachs
CE Celanese
$148.72 /

+0.105 (+0.07%)

CE Celanese
$148.72 /

+0.105 (+0.07%)

CE Celanese
$148.72 /

+0.105 (+0.07%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.